Cargando…
Combined sunitinib and radiation therapy for preoperative treatment of soft tissue sarcoma: results of a phase I trial of the German interdisciplinary sarcoma group (GISG-03)
BACKGROUND: Experimental data demonstrated that concurrent anti-angiogenic treatment with sunitinib may improve the efficacy of radiation therapy (RT). Here we report the results of a phase I trial performed within the German Interdisciplinary Sarcoma Group (GISG-03) of combined sunitinib and RT for...
Autores principales: | Jakob, Jens, Simeonova, Anna, Kasper, Bernd, Ronellenfitsch, Ulrich, Rauch, Geraldine, Wenz, Frederik, Hohenberger, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891890/ https://www.ncbi.nlm.nih.gov/pubmed/27255678 http://dx.doi.org/10.1186/s13014-016-0654-2 |
Ejemplares similares
-
Combination of Trabectedin and Gemcitabine for Advanced Soft Tissue Sarcomas: Results of a Phase I Dose Escalating Trial of the German Interdisciplinary Sarcoma Group (GISG)
por: Kasper, Bernd, et al.
Publicado: (2015) -
Preoperative therapy with pazopanib in high-risk soft tissue sarcoma: a phase II window-of-opportunity study by the German Interdisciplinary Sarcoma Group (GISG-04/NOPASS)
por: Ronellenfitsch, Ulrich, et al.
Publicado: (2016) -
Phase I trial of concurrent sunitinib and radiation therapy as preoperative treatment for soft tissue sarcoma
por: Jakob, Jens, et al.
Publicado: (2013) -
Molecular and Pathological Profiling of Corresponding Treatment-Naïve and Neoadjuvant Pazopanib-Treated High-Risk Soft Tissue Sarcoma Samples of the GISG-04/NOPASS Study
por: Gaiser, Timo, et al.
Publicado: (2021) -
Treatment of Angiosarcoma with Pazopanib and Paclitaxel: Results of the EVA (Evaluation of Votrient(®) in Angiosarcoma) Phase II Trial of the German Interdisciplinary Sarcoma Group (GISG-06)
por: Pink, Daniel, et al.
Publicado: (2021)